| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |